CN104825797A - Propolis-bitter gourd composite preparation - Google Patents
Propolis-bitter gourd composite preparation Download PDFInfo
- Publication number
- CN104825797A CN104825797A CN201510220235.6A CN201510220235A CN104825797A CN 104825797 A CN104825797 A CN 104825797A CN 201510220235 A CN201510220235 A CN 201510220235A CN 104825797 A CN104825797 A CN 104825797A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- radix
- bitter gourd
- propolis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a propolis-bitter gourd composite preparation, which comprises, by weight, 8-10 parts of a propolis extract, 6-8 parts of a bitter gourd extract, 3-5 parts of a mulberry leaf extract, 2-4 parts of a panax quinquefolius extract, 1-2 parts of a milkvetch root extract, 1-2 parts of a polygonatum odoratum extract, 2-3 parts of a ganoderma lucidum extract, 0.5-1 part of a radix rehmanniae preparata extract, 0.3-0.6 part of a fructus ligustri lucidi extract, 0.6-1.2 parts of a ophiopogon japonicas extract, 0.2-0.5 part of a gynostemma pentaphyllum extract, 2-4 parts of a fagopyrum tataricum extract, 0.3-0.8 part of chromium yeast, and 0.03-0.08 part of chromium picolinate. According to the present invention, the selected raw material ratio is scientific and reasonable, and human feeding trial results prove that the preparation has effects of good diabetes treatment and blood sugar lowering.
Description
Technical field
The present invention relates to a kind of medical functional product, especially one is used for the treatment of diabetes, hypoglycemic bee glue bitter gourd compound formulation.
Background technology
The metabolic disease of diabetes to be one group with hyperglycemia be feature.Diabetes are a kind of high-risk diseases, because diabetes are chronic diseases, and can bring increasing injury along with the development of the state of an illness to patient after falling ill, diabetes itself are not fearful, fearful is complication, and it not only can making patients's financial burden, also can make that patient is disabled, premature death.Along with the sickness rate of diabetes is more and more higher, the damaging range caused is also increasing.
Summary of the invention
The invention provides a kind of bee glue bitter gourd compound formulation, can be used for treating diabetes, blood sugar lowering.
The present invention realizes with following technical scheme: a kind of bee glue bitter gourd compound formulation, it is characterized in that it is made up of the common hybrid process of the raw material of following portions by weight: propolis extract 8-10 part, Fructus Momordicae charantiae extract 6-8 part, Folium Mori extract 3-5 part, Radix Panacis Quinquefolii extract 2-4 part, Radix Astragali extract 1-2 part, Rhizoma Polygonati Odorati extract 1-2 part, Ganoderma extract 2-3 part, Radix Rehmanniae Preparata extract 0.5-1 part, Fructus Ligustri Lucidi extract 0.3-0.6 part, Radix Ophiopogonis extract 0.6-1.2 part, Herb Gynostemmae Pentaphylli extract 0.2-0.5 part, Radix Et Rhizoma Fagopyri Tatarici extract 2-4 part, chromium yeast 0.3-0.8 part, chromium picolinate 0.03-0.08 part.
The present invention also discloses a kind of granule, tablet, hard capsule, soft capsule, adds adjuvant obtain through corresponding technique by aforementioned base materials.
Propolis is the resin that Apis gathers from plant spore or trunk, is mixed into palatine gland on it, a kind of colloidal solid thing with aromatic odor that the secretions of wax gland processes.Recent studies proves, abundant contained by propolis and the bioactive substance of uniqueness, has the several functions such as antibacterial, antiinflammatory, antipruritic, antioxidation, enhancing immunity, blood sugar lowering, blood fat reducing, antitumor, has medical, health-care effect widely to human body.Flavonoid in propolis and terpenoid substance have the effect promoting exogenous glucose synthesis hepatic glycogen and two-ways regulation blood glucose, significantly can reduce blood glucose.
Fructus Momordicae charantiae contains steroid saponin as Charantin, para-insulin peptide class and alkaloid, and it is active that these materials give balsam pear hypoglycemic.Charantin stimulates the release of insulin and hinders the formation of glucose in blood flow, and this function plays huge effect in diabetes particularly non-insulin-dependent diabetes mellitus treatment.
The invention has the beneficial effects as follows: the present invention utilizes pure natural Chinese herbal medicine and raw material to be prepared into treatment diabetes, hypoglycemic product, this formula studies science in strict accordance with theory of Chinese medical science and modern health preserving to draft, whole reasonable recipe, rigorous, the product of multiple dosage form can be prepared into, the cause of disease of existing hyperglycemia has been decided from human organism's Interior Solutions, raw material is easy to get, and preparation technology is relatively simple, is easy to industrialization and produces.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described further.
Embodiment 1
A kind of bee glue bitter gourd compound formulation, said preparation is prepared into hard capsule, and its component and parts by weight are: propolis extract 9 parts, Fructus Momordicae charantiae extract 7 parts, Folium Mori extract 3 parts, Radix Panacis Quinquefolii extract 2 parts, Radix Astragali extract 2 parts, Rhizoma Polygonati Odorati extract 1.5 parts, Ganoderma extract 2.5 parts, Radix Rehmanniae Preparata extract 0.8 part, Fructus Ligustri Lucidi extract 0.3 part, Radix Ophiopogonis extract 1 part, Herb Gynostemmae Pentaphylli extract 0.2 part, Radix Et Rhizoma Fagopyri Tatarici extract 4 parts, chromium yeast 0.3 part, chromium picolinate 0.07 part.By above-mentioned raw materials mix homogeneously, be filled in capsule shells by hard capsule automatic filling equipment, make hard capsule.
Lv, female, 44 years old, people from In Shandong Weihai, teacher, start to take capsule product prepared by the present embodiment in February, 2014, after three months, blood glucose target reached normal level.
Embodiment 2
A kind of bee glue bitter gourd compound formulation, said preparation is prepared into tablet, and its component and parts by weight are: propolis extract 8 parts, Fructus Momordicae charantiae extract 8 parts, Folium Mori extract 4 parts, Radix Panacis Quinquefolii extract 3 parts, Radix Astragali extract 1 part, Rhizoma Polygonati Odorati extract 2 parts, Ganoderma extract 2 parts, Radix Rehmanniae Preparata extract 0.6 part, Fructus Ligustri Lucidi extract 0.5 part, Radix Ophiopogonis extract 0.8 part, Herb Gynostemmae Pentaphylli extract 0.4 part, Radix Et Rhizoma Fagopyri Tatarici extract 2 parts, chromium yeast 0.5 part, chromium picolinate 0.05 part.Above-mentioned raw materials is added a certain amount of carboxymethyl starch sodium, after granulation, is pressed into plain sheet, coating, obtains tablet.
Summer so-and-so, man, 55 years old, people from In Shandong Weihai, printing house factory director, in December, 2013 started to take tablet prepared by the present embodiment, and after three months, blood glucose target reaches normal level.
Above to invention has been detailed introduction, the explanation of above embodiment just understands the present invention for helping.Those of ordinary skill in the art should be appreciated that to change technical scheme of the present invention, retouch or be equal to and replaces, and does not depart from the spirit and scope of technical solution of the present invention, and it all should belong in the middle of claims of the present invention.
Claims (2)
1. a bee glue bitter gourd compound formulation, is characterized in that it is made up of the common hybrid process of the raw material of following portions by weight: propolis extract 8-10 part, Fructus Momordicae charantiae extract 6-8 part, Folium Mori extract 3-5 part, Radix Panacis Quinquefolii extract 2-4 part, Radix Astragali extract 1-2 part, Rhizoma Polygonati Odorati extract 1-2 part, Ganoderma extract 2-3 part, Radix Rehmanniae Preparata extract 0.5-1 part, Fructus Ligustri Lucidi extract 0.3-0.6 part, Radix Ophiopogonis extract 0.6-1.2 part, Herb Gynostemmae Pentaphylli extract 0.2-0.5 part, Radix Et Rhizoma Fagopyri Tatarici extract 2-4 part, chromium yeast 0.3-0.8 part, chromium picolinate 0.03-0.08 part.
2. a bee glue bitter gourd compound formulation, is characterized in that, the raw material of claim 1 adds adjuvant through obtained granule, tablet, hard capsule, the soft capsule of corresponding technique.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510220235.6A CN104825797A (en) | 2015-05-04 | 2015-05-04 | Propolis-bitter gourd composite preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510220235.6A CN104825797A (en) | 2015-05-04 | 2015-05-04 | Propolis-bitter gourd composite preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104825797A true CN104825797A (en) | 2015-08-12 |
Family
ID=53804241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510220235.6A Pending CN104825797A (en) | 2015-05-04 | 2015-05-04 | Propolis-bitter gourd composite preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104825797A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105341908A (en) * | 2015-11-05 | 2016-02-24 | 四川知本生物工程有限公司 | Functional health-care food capsule and preparation method thereof |
| CN105533688A (en) * | 2015-12-11 | 2016-05-04 | 山西宝山鼎盛科技有限公司 | Healthcare soft capsule with assistant blood-sugar reducing effect and preparation method thereof |
| CN106236855A (en) * | 2016-08-25 | 2016-12-21 | 成都润馨堂药业有限公司 | A kind of compositions of assisting in reducing blood sugar |
| CN106237108A (en) * | 2016-08-18 | 2016-12-21 | 刘晓龙 | The formula of a kind of compound bee-glue and preparation method |
| CN106387867A (en) * | 2016-08-27 | 2017-02-15 | 桂林七星粉业有限责任公司 | Processing technology of tartarian buckwheat health-care capsules having effect of reducing blood sugar |
| WO2020113488A1 (en) * | 2018-12-06 | 2020-06-11 | 江苏安惠生物科技有限公司 | Granule having auxiliary hypoglycemic function |
| CN114558051A (en) * | 2022-03-14 | 2022-05-31 | 北京瑞草科技有限公司 | Chinese medicinal composition for treating diabetes and preparation method thereof |
-
2015
- 2015-05-04 CN CN201510220235.6A patent/CN104825797A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105341908A (en) * | 2015-11-05 | 2016-02-24 | 四川知本生物工程有限公司 | Functional health-care food capsule and preparation method thereof |
| CN105341908B (en) * | 2015-11-05 | 2018-06-29 | 四川知本生物工程有限公司 | A kind of functional health-care food capsule and preparation method thereof |
| CN105533688A (en) * | 2015-12-11 | 2016-05-04 | 山西宝山鼎盛科技有限公司 | Healthcare soft capsule with assistant blood-sugar reducing effect and preparation method thereof |
| CN106237108A (en) * | 2016-08-18 | 2016-12-21 | 刘晓龙 | The formula of a kind of compound bee-glue and preparation method |
| CN106236855A (en) * | 2016-08-25 | 2016-12-21 | 成都润馨堂药业有限公司 | A kind of compositions of assisting in reducing blood sugar |
| CN106387867A (en) * | 2016-08-27 | 2017-02-15 | 桂林七星粉业有限责任公司 | Processing technology of tartarian buckwheat health-care capsules having effect of reducing blood sugar |
| WO2020113488A1 (en) * | 2018-12-06 | 2020-06-11 | 江苏安惠生物科技有限公司 | Granule having auxiliary hypoglycemic function |
| CN114558051A (en) * | 2022-03-14 | 2022-05-31 | 北京瑞草科技有限公司 | Chinese medicinal composition for treating diabetes and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104825797A (en) | Propolis-bitter gourd composite preparation | |
| CN100404067C (en) | Traditional medicine preparation for treating children's pulmonary disease | |
| CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
| CN101708295A (en) | Chinese medicinal preparation for treating diabetes and preparation methods thereof | |
| CN103520586A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method therefor | |
| CN102085316A (en) | Medical composition with effect of tonifying spleen | |
| CN109288962A (en) | A kind of Chinese medicine composition for treating premature ovarian failure | |
| CN100536888C (en) | Traditional Chinese medicine preparation for treating chronic nephritis and nephrotic syndrome | |
| CN104138526B (en) | A kind of root of three-nerved spicebush iron sheet ginseng granules agent | |
| CN103768407B (en) | A kind of hypoglycemic compound capsule and preparation method thereof | |
| CN106362104A (en) | Pharmaceutical composition for treating polycystic ovary syndrome in adolescence | |
| CN104083640B (en) | Traditional Chinese medicinal composition for treating diabetes mellitus and preparation method thereof | |
| CN101314024A (en) | Traditional Chinese medicine capsule for treating AIDS | |
| CN101773624A (en) | Traditional Chinese medicine composition for curing diabetes and preparation method thereof | |
| CN103735843A (en) | Medicine composition for treating diabetes | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN113826882A (en) | Dietary nutrition supplement for preventing and treating diabetes and preparation process thereof | |
| CN103127272A (en) | Chinese medicinal preparation for treating breast disease and preparation method thereof | |
| WO2017101154A1 (en) | Stomach-nourishing traditional chinese medicine composition and preparation method therefor | |
| CN101062348B (en) | Ganoerma lucidum capusule for reducing blood sugar | |
| CN104173745A (en) | Nourishing and body-building Mongolian medicine | |
| CN103263580A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN106822852A (en) | Treat pharmaceutical composition, its preparation technology and the purposes of coronary heart disease | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN106344808A (en) | Compound dendrobium officinale health care product capable of assisting in reducing blood sugar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |
|
| WD01 | Invention patent application deemed withdrawn after publication |